Years after the U.S. began to slowly emerge from mandatory COVID-19 lockdowns, more than half of older adults still spend more time at home and less time socializing in public spaces than they did pre-pandemic, according to new University of Colorado Boulder research.
Nouscom extends Series C round to $82m for cancer vaccine trials – Pharmaceutical Technology
Share this article Switzerland-based Nouscom will use the funds to advance and expand its cancer vaccine clinical pipeline. Image credit: Shutterstock/eamesBot. Immuno-oncology company Nouscom has
March 21, 2024